Research Institute InnovAGe
The research institute InnovAGe (Innovative Drugs for an Aging Society) identifies and researches effective treatments for common age-related diseases: neurogenerative disorders and sarcopenia.
Its core mission is promoting young talent: InnovAGe’s doctoral researchers: From left to right: Mi Steinbach, Henrik Weber, Jan Hänsel, Irene Reimche, Christian Lamping, Sara Kopilas, Yuliya Richert, Duc Son Nguyen
(Image: Mi Steinbach)
As an institute within the Faculty of Applied Natural Sciences, InnovAGe has set itself the goal of making a significant contribution to drug discovery in age-related research areas such as neurogenerative diseases - including dementia - and sarcopenia (muscle weakness). Through close collaboration and networking among the various research areas of InnovAGe professors and cooperation with partners from science and research, optimal conditions are created to address a wide range of socio-relevant issues in this context. The research institute InnovAGe combines topics ranging from medical chemistry, molecular pharmacology, pharmaceutical technology, and computational intelligence.
The goal of the institute is to combine research activities in pharmaceutical fields across the university within InnovAGe in order to strengthen the research infrastructure.
The research institute InnovAGe has also set itself the goal of further sharpening the profile of the faculty and the university in the field of pharmaceutical research.
Close collaboration among multidisciplinary partners, from both research and industry, creates optimal research conditions. This enables successful knowledge transfer between InnovAGe and its various collaboration partners from universities, research institutions, and industry. In this way, InnovAge’s core mission - the structured support of early-career researchers through a successful implementation of collaborative doctoral programs within the university - can be carried out in the best possible environment.